Skip to Main Content

In an ambitious move to widen access to its medical products, Pfizer plans to provide nearly two dozen patent-protected medicines and vaccines, which are already available in the U.S. or European Union, at not-for-profit prices to 45 poor countries.

Under the initiative, Pfizer will start shipping its products — including its Covid-19 vaccine and antiviral pill — to Rwanda, Ghana, Malawi, Senegal, and Uganda later this year, although the effort will eventually focus on 27 low-income countries and another 18 lower-middle-income countries, most of which are located in Africa. Also on the list are Haiti, Bangladesh, and Tajikistan.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment